Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications (Q36912224)

17 August 2017

1 reference

title

Flow cytometric immunophenotyping of cancer cells in effusion specimens: diagnostic and research applications (English)

1 reference

17 August 2017

1 reference

Ben Davidson

1

1 reference

17 August 2017

Hiep Phuc Dong

2

1 reference

17 August 2017

Arild Holth

3

1 reference

17 August 2017

Aasmund Berner

4

1 reference

17 August 2017

Björn Risberg

5

1 reference

17 August 2017

publication date

1 September 2007

1 reference

17 August 2017

published in

Diagnostic Cytopathology

1 reference

17 August 2017

volume

35

1 reference

17 August 2017

issue

9

1 reference

17 August 2017

page(s)

568-578

1 reference

The role of conventional cytology, immunocytochemistry, and flow cytometric DNA ploidy in the evaluation of body cavity fluids: a prospective study of 52 patients

17 August 2017

cites work

1 reference

CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells

21 January 2018

1 reference

Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production

21 January 2018

1 reference

Diagnostic problems in serous effusions

21 January 2018

1 reference

7 January 2021

U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry. Bethesda, Maryland, November 16-17, 1995

1 reference

7 January 2021

Flow cytometry and Feulgen cytophotometry in evaluation of effusions

1 reference

7 January 2021

Analysis of pleural effusions using automated flow cytometry

1 reference

7 January 2021

Detection of tumor cells in body cavity fluids by flow cytometric and immunocytochemical analysis

1 reference

7 January 2021

Analysis of pleural effusions using flow cytometry

1 reference

7 January 2021

Correlation between DNA content, expression of Ki-67 antigen of tumor cells and immunophenotype of lymphocytes from malignant pleural effusions

1 reference

7 January 2021

Expression of carcinoembryonic antigen in fresh human gastric cancer cells assessed by flow cytometry

1 reference

7 January 2021

Use of specimen mammography-guided FNA (fine-needle aspirates) for flow cytometric multiple marker analysis and immunophenotyping in breast cancer

1 reference

7 January 2021

CD56 expression of neuroendocrine neoplasms on immunophenotyping by flow cytometry: a novel diagnostic approach to fine-needle aspiration biopsy

1 reference

7 January 2021

Flow cytometry in the diagnosis of mediastinal tumors with emphasis on differentiating thymocytes from precursor T-lymphoblastic lymphoma/leukemia

1 reference

7 January 2021

Contribution of flow cytometry to the diagnosis of malignant and non malignant conditions in lymph node biopsies

1 reference

7 January 2021

Flow cytometric immunophenotyping of serous effusions and peritoneal washings: comparison with immunocytochemistry and morphological findings

1 reference

7 January 2021

Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers

1 reference

7 January 2021

Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues

1 reference

7 January 2021

N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas: a ThinPrep immunocytochemical study

1 reference

7 January 2021

Detection of monocyte/macrophage cell populations in effusions: a comparative study using flow cytometric immunophenotyping and immunocytochemistry

1 reference

7 January 2021

Detection of malignant epithelial cells in effusions using flow cytometric immunophenotyping: an analysis of 92 cases

1 reference

7 January 2021

The Immunohistochemical Diagnostic Panel for Epithelial Mesothelioma

1 reference

7 January 2021

Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas

1 reference

7 January 2021

Complementary value of five carcinoma markers for the diagnosis of malignant mesothelioma, adenocarcinoma metastasis, and reactive mesothelium in serous effusions

1 reference

7 January 2021

Perspectives on the significance of altered glycosylation of glycoproteins in cancer

1 reference

7 January 2021

Immunohistochemical study of mucin carbohydrates and core proteins in human ovarian tumors

1 reference

7 January 2021

Immunohistochemical evaluation of sialosyl-Tn antigens in various ovarian carcinomas

1 reference

7 January 2021

Expression of Tn and Sialyl-Tn Antigens in Tumor Tissues of the Ovary

1 reference

7 January 2021

1 reference

7 January 2021

Carbohydrate antigen expression in primary tumors, metastatic lesions, and serous effusions from patients diagnosed with epithelial ovarian carcinoma: evidence of up-regulated Tn and Sialyl Tn antigen expression in effusions

1 reference

7 January 2021

Cadherin expression in ovarian carcinoma and malignant mesothelioma cell effusions

1 reference

7 January 2021

Role of integrins in cell invasion and migration

1 reference

7 January 2021

The role of integrins in tumorigenesis and metastasis

1 reference

7 January 2021

Evidence for preferential adhesion of ovarian epithelial carcinoma cells to type I collagen mediated by the alpha2beta1 integrin

1 reference

7 January 2021

alphavbeta3 and vitronectin expression by normal ovarian surface epithelial cells: role in cell adhesion and cell proliferation

1 reference

7 January 2021

Migration properties of the human ovarian adenocarcinoma cell line IGROV1: importance of alpha(v)beta3 integrins and vitronectin

1 reference

7 January 2021

Expression and Function of β1 and αvβ3 Integrins in Ovarian Cancer

1 reference

7 January 2021

Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro

1 reference

7 January 2021

Expression and localization of alpha v integrins and their ligand vitronectin in normal ovarian epithelium and in ovarian carcinoma

1 reference

7 January 2021

Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas

1 reference

7 January 2021

AlphaV- and beta1-integrin subunits are commonly expressed in malignant effusions from ovarian carcinoma patients

1 reference

7 January 2021

Differential motile response of human malignant mesothelioma cells to fibronectin, laminin and collagen type IV: the role of beta1 integrins

1 reference

7 January 2021

Pleural mesotheliomas have an integrin profile distinct from visceral carcinomas

1 reference

7 January 2021

Expression of beta 1, beta 3, beta 4, and beta 5 integrins by human lung carcinoma cells of different histotypes

1 reference

7 January 2021

Expression and function of receptors for extracellular matrix proteins in human ductal adenocarcinomas of the pancreas

1 reference

7 January 2021

Integrin alphavbeta3 promotes anchorage-dependent apoptosis in human intestinal carcinoma cells

1 reference

7 January 2021

Integrins in head and neck squamous cell carcinoma invasion

1 reference

7 January 2021

Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets

1 reference

7 January 2021

Expression of the 67 kDa laminin receptor and the alpha6 integrin subunit in serous ovarian carcinoma

1 reference

7 January 2021

The 67 kDa laminin receptor as a prognostic factor in human cancer

1 reference

7 January 2021

Quantitative analysis of integrin expression in effusions using flow cytometric immunophenotyping

1 reference

7 January 2021

Human NK cells and their receptors.

1 reference

7 January 2021

HLA-G polymorphisms and molecule function--questions and more questions--a review

1 reference

7 January 2021

The selection of tumor variants with altered expression of classical and nonclassical MHC class I molecules: implications for tumor immune escape.

1 reference

7 January 2021

HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis

1 reference

7 January 2021

Expression of HLA G in human tumors is not a frequent event.

1 reference

7 January 2021

HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance

1 reference

7 January 2021

Specific activation of the non-classical class I histocompatibility HLA-G antigen and expression of the ILT2 inhibitory receptor in human breast cancer

1 reference

7 January 2021

HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas

1 reference

7 January 2021

HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma

1 reference

7 January 2021

Class I histocompatibility antigen expression: a prognostic factor for aneuploid ovarian cancers

1 reference

7 January 2021

Frequent loss of HLA-A2 expression in metastasizing ovarian carcinomas associated with genomic haplotype loss and HLA-A2-restricted HER-2/neu-specific immunity.

1 reference

7 January 2021

Expression of HLA-G in malignant mesothelioma and clinically aggressive breast carcinoma.

1 reference

7 January 2021

Chemokines: agents for the immunotherapy of cancer?

1 reference

7 January 2021

Identification of Biologically Active Chemokine Isoforms from Ascitic Fluid and Elevated Levels of CCL18/Pulmonary and Activation-regulated Chemokine in Ovarian Carcinoma

1 reference

7 January 2021

Mesothelioma environment comprises cytokines and T-regulatory cells that suppress immune responses

1 reference

7 January 2021

Chemokine receptors are infrequently expressed in malignant and benign mesothelial cells

1 reference

7 January 2021

Macrophages: Obligate Partners for Tumor Cell Migration, Invasion, and Metastasis

1 reference

7 January 2021

Distinct role of macrophages in different tumor microenvironments

1 reference

7 January 2021

Identifiers

DOI

10.1002/DC.20707

1 reference

17 August 2017

1 reference